Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Period	Debt/Equity
2016-12-31	0.60
2017-12-31	0.88
2018-12-31	0.63
2019-12-31	0.57
2020-12-31	0.73
2021-12-31	0.74
2022-12-31	2.50
2023-12-31	1.96
2024-12-31	1.54

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$522.84	+2.82%	0.28M
3
4
5

Medpace Holdings Inc. (MEDP) Debt to Equity Ratio

Debt to Equity Ratio Data

Get Medpace Holdings Inc. Data in Excel

More MEDP Financial Data